Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIGO antisense RNA 1 (PIGO-AS1)
- Target
- PIGO-AS1
- Molecular classification
- Antisense long non-coding RNA (lncRNA), Other (Non-coding RNA)
01
Overview
PIGO antisense RNA 1 (PIGO-AS1) is a long non-coding RNA (lncRNA) transcribed from the opposite strand of the PIGO gene locus. Like other antisense lncRNAs, PIGO-AS1 does not encode a protein but may regulate the expression of the sense gene, PIGO, potentially through mechanisms such as RNA-RNA interaction, modulation of local chromatin state, or transcriptional interference. While many antisense lncRNAs have been implicated in the regulation of gene expression and play roles in diseases like cancer, there is currently no direct evidence linking PIGO-AS1 to any specific disease or therapeutic mechanism. Its specific biological function and involvement in human pathology remain to be characterized.
- Other names
- PIGO-AS1
02
Mechanism of action
Not established; in analogy with other antisense lncRNAs, might modulate the expression of its sense gene (PIGO) through RNA-RNA interactions or chromatin modification pathways
03
Biological functions
Regulation of gene expression (especially of the PIGO gene)Possible roles in chromatin modification and transcription regulation, by analogy to other antisense lncRNAs
04
Disease associations
Other (No direct disease association found; generally, antisense lncRNAs may be implicated in disease through epigenetic or post-transcriptional gene regulation)
Beyond the preview
Go deeper on PIGO antisense RNA 1 (PIGO-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PIGO antisense RNA 1 (PIGO-AS1).